ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 77

Single Nucleotide Polymorphism in the Gene Encoding Peptidylarginine Deiminase 4 Correlates with Reduced Neutrophil Extracellular Traps and Anti-Histone Antibodies in Rheumatoid Arthritis

Aisha M. Mergaert1, Mandar Bawadekar2, Thai Q. Nguyen1, Steven J. Schrodi3,4 and Miriam A. Shelef2,5, 1University of Wisconsin - Madison, Madison, WI, 2Department of Medicine, Division of Rheumatology, University of Wisconsin - Madison, Madison, WI, 3Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI, 4Computation and Informatics in Biology and Medicine, University of Wisconsin - Madison, Madison, WI, 5William S. Middleton Memorial Veterans Hospital, Madison, WI

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: autoantibodies and rheumatoid arthritis (RA), Neutrophil Extracellular Traps, PAD

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: In neutrophils, peptidylarginine deiminase 4 (PAD4) citrullinates histones allowing chromatin unraveling and neutrophil extracellular trap (NET) formation. NETs are increased and display proteins targeted by autoantibodies in rheumatoid arthritis. Interestingly, antibodies against citrullinated histones are among the first autoantibodies detected in rheumatoid arthritis. Thus, PAD4 may contribute to the development of rheumatoid arthritis by inducing NETs and ultimately autoantibodies. Murine studies have demonstrated that PAD4-deficient mice have reduced NETosis, autoantibodies, and inflammatory arthritis, but the effects of a loss of PAD4 in humans is unknown. Recently it has been shown that the G allele of single nucleotide polymorphism (SNP) rs2240335 in PADI4 is associated with decreased expression of PAD4 in human neutrophils in healthy Caucasians. The purpose of this study is to determine if the G allele of rs2240335 correlates with reduced NETs and autoantibodies against citrullinated histones in humans, similar to the PAD4 knockout studies in mice.

Methods: DNA, plasma, and serum from subjects with rheumatoid arthritis, both anti-cyclic citrullinated peptide (CCP) antibody negative (n=44) and positive (n=71), and controls (n=28) were obtained from our biorepository. Subjects were ~90% Caucasian. DNA was genotyped at rs2240335. Plasma from controls homozygous at rs2240335 was subjected to an enzyme linked immunosorbent assay (ELISA) to quantify circulating NETs. Serum from rheumatoid arthritis subjects homozygous at rs2240335 was subjected to ELISA to quantify IgG that binds native histones and histones in vitro citrullinated with human PAD4. Results were compared between genotypes using a student’s t test and verified by a permutation routine.

Results: The concentration of circulating NETs is significantly lower in controls homozygous for the G allele at rs2240335 compared to homozygotes for the T allele (p=0.027). In CCP+ rheumatoid arthritis subjects, there was no significant difference in anti-native and anti-citrullinated histone H1, H2A, H2B, H3, and H4 antibody levels between genotypes. However, for CCP- rheumatoid arthritis subjects, anti-citrullinated histone H2B (p=0.036) and H3 (p=0.0041) and anti-native histone H2A (p=0.0064), H2B (p=0.0073), and H3 (p=0.030) antibody levels were decreased in subjects with the GG genotype.

Conclusion: Similar to studies in PAD4-deficient mice, the G allele of SNP rs2240335, which has been shown to be associated with reduced PAD4 expression in human neutrophils, correlates with reduced NETosis in controls and reduced anti-histone antibodies in CCP- rheumatoid arthritis. Further studies are needed to determine if this allele is associated with rheumatoid arthritis risk in Caucasians.


Disclosure: A. M. Mergaert, None; M. Bawadekar, None; T. Q. Nguyen, None; S. J. Schrodi, None; M. A. Shelef, None.

To cite this abstract in AMA style:

Mergaert AM, Bawadekar M, Nguyen TQ, Schrodi SJ, Shelef MA. Single Nucleotide Polymorphism in the Gene Encoding Peptidylarginine Deiminase 4 Correlates with Reduced Neutrophil Extracellular Traps and Anti-Histone Antibodies in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/single-nucleotide-polymorphism-in-the-gene-encoding-peptidylarginine-deiminase-4-correlates-with-reduced-neutrophil-extracellular-traps-and-anti-histone-antibodies-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-nucleotide-polymorphism-in-the-gene-encoding-peptidylarginine-deiminase-4-correlates-with-reduced-neutrophil-extracellular-traps-and-anti-histone-antibodies-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology